Ignite Creation Date:
2024-05-06 @ 8:07 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02674802
Status:
UNKNOWN
Last Update Posted:
2016-02-04
First Post:
2016-02-02
Brief Title:
Reinfection After Eradication of Helicobacter Pylori Infection
Sponsor:
The First Affiliated Hospital of Nanchang University
Organization:
The First Affiliated Hospital of Nanchang University
Study Overview
Official Title:
Reinfection After Eradication of Helicobacter Pylori Infection in Adult A National Multicentre Study
Status:
UNKNOWN
Status Verified Date:
2016-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RAEHPI
Brief Summary:
Helicobacter pylori is closely related with gastritis peptic ulcer gastric cancer and gastric MALT lymphoma and it may participate in a variety of parenteral diseases Infection rates of Helicobacter pylori is still high so effectively eradication is necessary At present the eradication therapy has achieved very good curative effect However relapse after eradication is unoptimistic This study has made an analysis for reinfection after eradication of Helicobacter pylori Infection include the retrospective and prospective studies aims to explore the epidemiological data and related risk factors of Hp reinfection in China
Detailed Description:
In the retrospective studywe choose the people received regular eradication therapy successfully eradicated helicobacter pylori more than six months but 4 to 8 weeks after drug withdrawal the detection result of helicobacter pylori were negative to ensure that the results of the study is the reinfection not residual Even more noteworthy is during the treatment and detection again the patients must not received any eradication therapy of Hp Whats more before the detection they also has not used antibiotics bismuth agent and the traditional Chinese medicine with antibacterial effect in 1 monthor and has not used H2RA and PPI in 2 weeks to prevent affecting the accuracy of the results At the same time we also investigated the patients general situation conomic conditions living conditions personal health and lifestyle to explore related risk factors of Hp reinfection in China In the prospective study we detected Hp by C-UBT after regular eradication therapy of Hp for 4 weeks 8 weeks and 6 months to prospect the reinfection of HpIt also can make up the defects of retrospective study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None